Exponent (NASDAQ:EXPO) Q4 CY2025 Revenue Surpasses Estimates, EPS Up 3.7%

Exponent (NASDAQ:EXPO) posted Q4 CY2025 revenue of $147.4 million, up 19.1% year-on-year, and GAAP earnings of $0.49 per share, 3.7% above consensus. The operating margin contracted to 19.8% from 22.1% YoY, and the company’s 5-year average operating margin remains 24.3%. With a strong R&D base of over 800 advanced-degree consultants, Exponent delivered a solid finish to 2025, outperforming revenue and EPS expectations. Analysts project CY2026 revenue to grow 4.1% and full-year EPS of $2.07, up 7.8% from 2025. Publication Date: February 5, 2026